A Phase II Trial Measuring the Integration of Stereotactic Ablative Radiation Therapy (SABR) Plus Surgery for Early-Stage Non-Small Cell Lung Cancer (MISSILE-NSCLC): Interim Safety Results
2016 ◽
Vol 96
(2)
◽
pp. E473
2018 ◽
Vol 102
(3)
◽
pp. e706
2012 ◽
Vol 84
(3)
◽
pp. S820
◽
2018 ◽
Vol 102
(3)
◽
pp. e696
2015 ◽
Vol 10
(6)
◽
pp. 872-882
◽
2014 ◽
Vol 90
(5)
◽
pp. S12